Levothyroxine clinical trials

Explore recruiting levothyroxine clinical trials.

Recruiting levothyroxine studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Levothyroxine trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Impact of Early Thyroid Hormone Replacement on Kidney Function and Health-Related Quality of Life in Patients at Risk of Postoperative Hypothyroidism after Hemithyroidectomy: A Randomised Controlled Trial

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

Effect of levothyroxine as adjuvant therapy to a hypocaloric diet in the treatment of obesity: a randomized placebo-controlled trial.

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Impact of levothyroxine on erectile function measured by the IIEF-15, EHS, PGIC and EDITS questionnaires in patients with hypothyroidism. Prospective, randomized controlled clinical trial with sildenafil 100

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Multicentric phase III trial comparing two strategies in intermediate-risk differentiated thyroid cancer patients: Systematic radioiodine administration versus decision of radioiodine treatment guided by a post-operative work-up based on serum Tg values and diagnostic RAI scintigraphy

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A national randomized placebo-controlled double-blind multicenter trial of LT4/LT3 combination therapy in patients with autoimmune hypothyroidism: the T3-4-Hypo trial

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

Levothyroxine trials by city

Levothyroxine in Toronto Levothyroxine in Vancouver Levothyroxine in Montreal Levothyroxine in Calgary Levothyroxine in Edmonton Levothyroxine in Ottawa Levothyroxine in Winnipeg Levothyroxine in Quebec City Levothyroxine in Hamilton Levothyroxine in Kitchener Levothyroxine in London Levothyroxine in Halifax Levothyroxine in New York Levothyroxine in Los Angeles Levothyroxine in Chicago Levothyroxine in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease